Finally, we observed that two vaccine doses induced, in the majority of the participants, undetectable levels of IgM and detectable levels of IgA specific for SARS-CoV-2 S, which were higher in previously infected HC and HD participants vaccinated with BNT162b2 and in naïve HD patients vaccinated with mRNA-1273 compared to naïve HD vaccinated with BNT162b2, and correlated with the corresponding IgG levels (Fig 1E–1G and S2 Fig, panels b and c). This evidence concerns the gene CD79A and Huntington disease.